Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$RARE Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$1.16 up 35.91% YoY • Reported revenue of $173M up 8.17% YoY • Ultragenyx reaffirmed full-year 2026 total revenue guidance of $730M to $760M, excluding new product launches; 2027 R&D expenses expected to be less than $350M and SG&A expenses less than $375M.
2

Price since post

Full Details

Advertisement|Remove ads.